Dr Agarwal's Health Care Halts Trading for FY26 Results

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
Dr Agarwal's Health Care Halts Trading for FY26 Results
Overview

Dr. Agarwal's Health Care Limited will shut its trading window for employees and insiders starting March 31, 2026. This is a standard step taken while the company finalizes its audited financial results for fiscal year 2026. The window will reopen 48 hours after the results are officially announced.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Dr. Agarwal's Health Care Limited announced it will close its trading window for designated persons starting March 31, 2026. This move is a routine measure to comply with insider trading regulations as the company prepares to announce its audited financial results for fiscal year 2026.

The restriction applies to company insiders and their immediate relatives, preventing them from trading the company's shares until the results are made public. The trading window is set to reopen 48 hours after the official announcement of these results, subject to board approval.

This practice is standard across listed Indian companies, including peers like Laurus Labs Limited and Divi's Laboratories Limited. Such measures help ensure transparency and a level playing field for all investors by preventing insider trading.

The exact date for the announcement of the FY26 results has not yet been communicated, leaving investors to await further updates from the company.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.